Global Ankylosing Spondylitis Drug Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 299215
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Ankylosing Spondylitis Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Ankylosing Spondylitis Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Ankylosing Spondylitis Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Cimzia segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Ankylosing Spondylitis Drug include Amgen, Wyeth, Takeda, Centocor, and Schering-Plough, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Ankylosing Spondylitis Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Cimzia

Enbrel

Humira

Remicade

Simponi

Others

Market segment by Application, can be divided into

Hospitals

Clinics

Market segment by players, this report covers

Amgen

Wyeth

Takeda

Centocor

Schering-Plough

Mitsubishi Tanabe

Abbott

Eisai

Pfizer

Johnson & Johnson

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Ankylosing Spondylitis Drug product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Ankylosing Spondylitis Drug, with revenue, gross margin and global market share of Ankylosing Spondylitis Drug from 2019 to 2022.

Chapter 3, the Ankylosing Spondylitis Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Ankylosing Spondylitis Drug market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Ankylosing Spondylitis Drug research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Ankylosing Spondylitis Drug

1.2 Classification of Ankylosing Spondylitis Drug by Type

1.2.1 Overview: Global Ankylosing Spondylitis Drug Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Ankylosing Spondylitis Drug Revenue Market Share by Type in 2021

1.2.3 Cimzia

1.2.4 Enbrel

1.2.5 Humira

1.2.6 Remicade

1.2.7 Simponi

1.2.8 Others

1.3 Global Ankylosing Spondylitis Drug Market by Application

1.3.1 Overview: Global Ankylosing Spondylitis Drug Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospitals

1.3.3 Clinics

1.4 Global Ankylosing Spondylitis Drug Market Size & Forecast

1.5 Global Ankylosing Spondylitis Drug Market Size and Forecast by Region

1.5.1 Global Ankylosing Spondylitis Drug Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Ankylosing Spondylitis Drug Market Size by Region, (2017-2022)

1.5.3 North America Ankylosing Spondylitis Drug Market Size and Prospect (2017-2028)

1.5.4 Europe Ankylosing Spondylitis Drug Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Ankylosing Spondylitis Drug Market Size and Prospect (2017-2028)

1.5.6 South America Ankylosing Spondylitis Drug Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Ankylosing Spondylitis Drug Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Ankylosing Spondylitis Drug Market Drivers

1.6.2 Ankylosing Spondylitis Drug Market Restraints

1.6.3 Ankylosing Spondylitis Drug Trends Analysis

2 Company Profiles

2.1 Amgen

2.1.1 Amgen Details

2.1.2 Amgen Major Business

2.1.3 Amgen Ankylosing Spondylitis Drug Product and Solutions

2.1.4 Amgen Ankylosing Spondylitis Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Amgen Recent Developments and Future Plans

2.2 Wyeth

2.2.1 Wyeth Details

2.2.2 Wyeth Major Business

2.2.3 Wyeth Ankylosing Spondylitis Drug Product and Solutions

2.2.4 Wyeth Ankylosing Spondylitis Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Wyeth Recent Developments and Future Plans

2.3 Takeda

2.3.1 Takeda Details

2.3.2 Takeda Major Business

2.3.3 Takeda Ankylosing Spondylitis Drug Product and Solutions

2.3.4 Takeda Ankylosing Spondylitis Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Takeda Recent Developments and Future Plans

2.4 Centocor

2.4.1 Centocor Details

2.4.2 Centocor Major Business

2.4.3 Centocor Ankylosing Spondylitis Drug Product and Solutions

2.4.4 Centocor Ankylosing Spondylitis Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Centocor Recent Developments and Future Plans

2.5 Schering-Plough

2.5.1 Schering-Plough Details

2.5.2 Schering-Plough Major Business

2.5.3 Schering-Plough Ankylosing Spondylitis Drug Product and Solutions

2.5.4 Schering-Plough Ankylosing Spondylitis Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Schering-Plough Recent Developments and Future Plans

2.6 Mitsubishi Tanabe

2.6.1 Mitsubishi Tanabe Details

2.6.2 Mitsubishi Tanabe Major Business

2.6.3 Mitsubishi Tanabe Ankylosing Spondylitis Drug Product and Solutions

2.6.4 Mitsubishi Tanabe Ankylosing Spondylitis Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Mitsubishi Tanabe Recent Developments and Future Plans

2.7 Abbott

2.7.1 Abbott Details

2.7.2 Abbott Major Business

2.7.3 Abbott Ankylosing Spondylitis Drug Product and Solutions

2.7.4 Abbott Ankylosing Spondylitis Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Abbott Recent Developments and Future Plans

2.8 Eisai

2.8.1 Eisai Details

2.8.2 Eisai Major Business

2.8.3 Eisai Ankylosing Spondylitis Drug Product and Solutions

2.8.4 Eisai Ankylosing Spondylitis Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Eisai Recent Developments and Future Plans

2.9 Pfizer

2.9.1 Pfizer Details

2.9.2 Pfizer Major Business

2.9.3 Pfizer Ankylosing Spondylitis Drug Product and Solutions

2.9.4 Pfizer Ankylosing Spondylitis Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Pfizer Recent Developments and Future Plans

2.10 Johnson & Johnson

2.10.1 Johnson & Johnson Details

2.10.2 Johnson & Johnson Major Business

2.10.3 Johnson & Johnson Ankylosing Spondylitis Drug Product and Solutions

2.10.4 Johnson & Johnson Ankylosing Spondylitis Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Johnson & Johnson Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Ankylosing Spondylitis Drug Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Ankylosing Spondylitis Drug Players Market Share in 2021

3.2.2 Top 10 Ankylosing Spondylitis Drug Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Ankylosing Spondylitis Drug Players Head Office, Products and Services Provided

3.4 Ankylosing Spondylitis Drug Mergers & Acquisitions

3.5 Ankylosing Spondylitis Drug New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Ankylosing Spondylitis Drug Revenue and Market Share by Type (2017-2022)

4.2 Global Ankylosing Spondylitis Drug Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Ankylosing Spondylitis Drug Revenue Market Share by Application (2017-2022)

5.2 Global Ankylosing Spondylitis Drug Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Ankylosing Spondylitis Drug Revenue by Type (2017-2028)

6.2 North America Ankylosing Spondylitis Drug Revenue by Application (2017-2028)

6.3 North America Ankylosing Spondylitis Drug Market Size by Country

6.3.1 North America Ankylosing Spondylitis Drug Revenue by Country (2017-2028)

6.3.2 United States Ankylosing Spondylitis Drug Market Size and Forecast (2017-2028)

6.3.3 Canada Ankylosing Spondylitis Drug Market Size and Forecast (2017-2028)

6.3.4 Mexico Ankylosing Spondylitis Drug Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Ankylosing Spondylitis Drug Revenue by Type (2017-2028)

7.2 Europe Ankylosing Spondylitis Drug Revenue by Application (2017-2028)

7.3 Europe Ankylosing Spondylitis Drug Market Size by Country

7.3.1 Europe Ankylosing Spondylitis Drug Revenue by Country (2017-2028)

7.3.2 Germany Ankylosing Spondylitis Drug Market Size and Forecast (2017-2028)

7.3.3 France Ankylosing Spondylitis Drug Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Ankylosing Spondylitis Drug Market Size and Forecast (2017-2028)

7.3.5 Russia Ankylosing Spondylitis Drug Market Size and Forecast (2017-2028)

7.3.6 Italy Ankylosing Spondylitis Drug Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Ankylosing Spondylitis Drug Revenue by Type (2017-2028)

8.2 Asia-Pacific Ankylosing Spondylitis Drug Revenue by Application (2017-2028)

8.3 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Region

8.3.1 Asia-Pacific Ankylosing Spondylitis Drug Revenue by Region (2017-2028)

8.3.2 China Ankylosing Spondylitis Drug Market Size and Forecast (2017-2028)

8.3.3 Japan Ankylosing Spondylitis Drug Market Size and Forecast (2017-2028)

8.3.4 South Korea Ankylosing Spondylitis Drug Market Size and Forecast (2017-2028)

8.3.5 India Ankylosing Spondylitis Drug Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Ankylosing Spondylitis Drug Market Size and Forecast (2017-2028)

8.3.7 Australia Ankylosing Spondylitis Drug Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Ankylosing Spondylitis Drug Revenue by Type (2017-2028)

9.2 South America Ankylosing Spondylitis Drug Revenue by Application (2017-2028)

9.3 South America Ankylosing Spondylitis Drug Market Size by Country

9.3.1 South America Ankylosing Spondylitis Drug Revenue by Country (2017-2028)

9.3.2 Brazil Ankylosing Spondylitis Drug Market Size and Forecast (2017-2028)

9.3.3 Argentina Ankylosing Spondylitis Drug Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Ankylosing Spondylitis Drug Revenue by Type (2017-2028)

10.2 Middle East & Africa Ankylosing Spondylitis Drug Revenue by Application (2017-2028)

10.3 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Country

10.3.1 Middle East & Africa Ankylosing Spondylitis Drug Revenue by Country (2017-2028)

10.3.2 Turkey Ankylosing Spondylitis Drug Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Ankylosing Spondylitis Drug Market Size and Forecast (2017-2028)

10.3.4 UAE Ankylosing Spondylitis Drug Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Ankylosing Spondylitis Drug Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Ankylosing Spondylitis Drug Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Ankylosing Spondylitis Drug Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Ankylosing Spondylitis Drug Revenue (USD Million) by Region (2017-2022)

Table 5. Global Ankylosing Spondylitis Drug Revenue Market Share by Region (2023-2028)

Table 6. Amgen Corporate Information, Head Office, and Major Competitors

Table 7. Amgen Major Business

Table 8. Amgen Ankylosing Spondylitis Drug Product and Solutions

Table 9. Amgen Ankylosing Spondylitis Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Wyeth Corporate Information, Head Office, and Major Competitors

Table 11. Wyeth Major Business

Table 12. Wyeth Ankylosing Spondylitis Drug Product and Solutions

Table 13. Wyeth Ankylosing Spondylitis Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Takeda Corporate Information, Head Office, and Major Competitors

Table 15. Takeda Major Business

Table 16. Takeda Ankylosing Spondylitis Drug Product and Solutions

Table 17. Takeda Ankylosing Spondylitis Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Centocor Corporate Information, Head Office, and Major Competitors

Table 19. Centocor Major Business

Table 20. Centocor Ankylosing Spondylitis Drug Product and Solutions

Table 21. Centocor Ankylosing Spondylitis Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Schering-Plough Corporate Information, Head Office, and Major Competitors

Table 23. Schering-Plough Major Business

Table 24. Schering-Plough Ankylosing Spondylitis Drug Product and Solutions

Table 25. Schering-Plough Ankylosing Spondylitis Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Mitsubishi Tanabe Corporate Information, Head Office, and Major Competitors

Table 27. Mitsubishi Tanabe Major Business

Table 28. Mitsubishi Tanabe Ankylosing Spondylitis Drug Product and Solutions

Table 29. Mitsubishi Tanabe Ankylosing Spondylitis Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Abbott Corporate Information, Head Office, and Major Competitors

Table 31. Abbott Major Business

Table 32. Abbott Ankylosing Spondylitis Drug Product and Solutions

Table 33. Abbott Ankylosing Spondylitis Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Eisai Corporate Information, Head Office, and Major Competitors

Table 35. Eisai Major Business

Table 36. Eisai Ankylosing Spondylitis Drug Product and Solutions

Table 37. Eisai Ankylosing Spondylitis Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Pfizer Corporate Information, Head Office, and Major Competitors

Table 39. Pfizer Major Business

Table 40. Pfizer Ankylosing Spondylitis Drug Product and Solutions

Table 41. Pfizer Ankylosing Spondylitis Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 43. Johnson & Johnson Major Business

Table 44. Johnson & Johnson Ankylosing Spondylitis Drug Product and Solutions

Table 45. Johnson & Johnson Ankylosing Spondylitis Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Global Ankylosing Spondylitis Drug Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 47. Global Ankylosing Spondylitis Drug Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 48. Breakdown of Ankylosing Spondylitis Drug by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Ankylosing Spondylitis Drug Players Head Office, Products and Services Provided

Table 50. Ankylosing Spondylitis Drug Mergers & Acquisitions in the Past Five Years

Table 51. Ankylosing Spondylitis Drug New Entrants and Expansion Plans

Table 52. Global Ankylosing Spondylitis Drug Revenue (USD Million) by Type (2017-2022)

Table 53. Global Ankylosing Spondylitis Drug Revenue Share by Type (2017-2022)

Table 54. Global Ankylosing Spondylitis Drug Revenue Forecast by Type (2023-2028)

Table 55. Global Ankylosing Spondylitis Drug Revenue by Application (2017-2022)

Table 56. Global Ankylosing Spondylitis Drug Revenue Forecast by Application (2023-2028)

Table 57. North America Ankylosing Spondylitis Drug Revenue by Type (2017-2022) & (USD Million)

Table 58. North America Ankylosing Spondylitis Drug Revenue by Type (2023-2028) & (USD Million)

Table 59. North America Ankylosing Spondylitis Drug Revenue by Application (2017-2022) & (USD Million)

Table 60. North America Ankylosing Spondylitis Drug Revenue by Application (2023-2028) & (USD Million)

Table 61. North America Ankylosing Spondylitis Drug Revenue by Country (2017-2022) & (USD Million)

Table 62. North America Ankylosing Spondylitis Drug Revenue by Country (2023-2028) & (USD Million)

Table 63. Europe Ankylosing Spondylitis Drug Revenue by Type (2017-2022) & (USD Million)

Table 64. Europe Ankylosing Spondylitis Drug Revenue by Type (2023-2028) & (USD Million)

Table 65. Europe Ankylosing Spondylitis Drug Revenue by Application (2017-2022) & (USD Million)

Table 66. Europe Ankylosing Spondylitis Drug Revenue by Application (2023-2028) & (USD Million)

Table 67. Europe Ankylosing Spondylitis Drug Revenue by Country (2017-2022) & (USD Million)

Table 68. Europe Ankylosing Spondylitis Drug Revenue by Country (2023-2028) & (USD Million)

Table 69. Asia-Pacific Ankylosing Spondylitis Drug Revenue by Type (2017-2022) & (USD Million)

Table 70. Asia-Pacific Ankylosing Spondylitis Drug Revenue by Type (2023-2028) & (USD Million)

Table 71. Asia-Pacific Ankylosing Spondylitis Drug Revenue by Application (2017-2022) & (USD Million)

Table 72. Asia-Pacific Ankylosing Spondylitis Drug Revenue by Application (2023-2028) & (USD Million)

Table 73. Asia-Pacific Ankylosing Spondylitis Drug Revenue by Region (2017-2022) & (USD Million)

Table 74. Asia-Pacific Ankylosing Spondylitis Drug Revenue by Region (2023-2028) & (USD Million)

Table 75. South America Ankylosing Spondylitis Drug Revenue by Type (2017-2022) & (USD Million)

Table 76. South America Ankylosing Spondylitis Drug Revenue by Type (2023-2028) & (USD Million)

Table 77. South America Ankylosing Spondylitis Drug Revenue by Application (2017-2022) & (USD Million)

Table 78. South America Ankylosing Spondylitis Drug Revenue by Application (2023-2028) & (USD Million)

Table 79. South America Ankylosing Spondylitis Drug Revenue by Country (2017-2022) & (USD Million)

Table 80. South America Ankylosing Spondylitis Drug Revenue by Country (2023-2028) & (USD Million)

Table 81. Middle East & Africa Ankylosing Spondylitis Drug Revenue by Type (2017-2022) & (USD Million)

Table 82. Middle East & Africa Ankylosing Spondylitis Drug Revenue by Type (2023-2028) & (USD Million)

Table 83. Middle East & Africa Ankylosing Spondylitis Drug Revenue by Application (2017-2022) & (USD Million)

Table 84. Middle East & Africa Ankylosing Spondylitis Drug Revenue by Application (2023-2028) & (USD Million)

Table 85. Middle East & Africa Ankylosing Spondylitis Drug Revenue by Country (2017-2022) & (USD Million)

Table 86. Middle East & Africa Ankylosing Spondylitis Drug Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Ankylosing Spondylitis Drug Picture

Figure 2. Global Ankylosing Spondylitis Drug Revenue Market Share by Type in 2021

Figure 3. Cimzia

Figure 4. Enbrel

Figure 5. Humira

Figure 6. Remicade

Figure 7. Simponi

Figure 8. Others

Figure 9. Ankylosing Spondylitis Drug Revenue Market Share by Application in 2021

Figure 10. Hospitals Picture

Figure 11. Clinics Picture

Figure 12. Global Ankylosing Spondylitis Drug Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 13. Global Ankylosing Spondylitis Drug Revenue and Forecast (2017-2028) & (USD Million)

Figure 14. Global Ankylosing Spondylitis Drug Revenue Market Share by Region (2017-2028)

Figure 15. Global Ankylosing Spondylitis Drug Revenue Market Share by Region in 2021

Figure 16. North America Ankylosing Spondylitis Drug Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Europe Ankylosing Spondylitis Drug Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Asia-Pacific Ankylosing Spondylitis Drug Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. South America Ankylosing Spondylitis Drug Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Middle East and Africa Ankylosing Spondylitis Drug Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Ankylosing Spondylitis Drug Market Drivers

Figure 22. Ankylosing Spondylitis Drug Market Restraints

Figure 23. Ankylosing Spondylitis Drug Market Trends

Figure 24. Amgen Recent Developments and Future Plans

Figure 25. Wyeth Recent Developments and Future Plans

Figure 26. Takeda Recent Developments and Future Plans

Figure 27. Centocor Recent Developments and Future Plans

Figure 28. Schering-Plough Recent Developments and Future Plans

Figure 29. Mitsubishi Tanabe Recent Developments and Future Plans

Figure 30. Abbott Recent Developments and Future Plans

Figure 31. Eisai Recent Developments and Future Plans

Figure 32. Pfizer Recent Developments and Future Plans

Figure 33. Johnson & Johnson Recent Developments and Future Plans

Figure 34. Global Ankylosing Spondylitis Drug Revenue Share by Players in 2021

Figure 35. Ankylosing Spondylitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 36. Global Top 3 Players Ankylosing Spondylitis Drug Revenue Market Share in 2021

Figure 37. Global Top 10 Players Ankylosing Spondylitis Drug Revenue Market Share in 2021

Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 39. Global Ankylosing Spondylitis Drug Revenue Share by Type in 2021

Figure 40. Global Ankylosing Spondylitis Drug Market Share Forecast by Type (2023-2028)

Figure 41. Global Ankylosing Spondylitis Drug Revenue Share by Application in 2021

Figure 42. Global Ankylosing Spondylitis Drug Market Share Forecast by Application (2023-2028)

Figure 43. North America Ankylosing Spondylitis Drug Sales Market Share by Type (2017-2028)

Figure 44. North America Ankylosing Spondylitis Drug Sales Market Share by Application (2017-2028)

Figure 45. North America Ankylosing Spondylitis Drug Revenue Market Share by Country (2017-2028)

Figure 46. United States Ankylosing Spondylitis Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Canada Ankylosing Spondylitis Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Mexico Ankylosing Spondylitis Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Europe Ankylosing Spondylitis Drug Sales Market Share by Type (2017-2028)

Figure 50. Europe Ankylosing Spondylitis Drug Sales Market Share by Application (2017-2028)

Figure 51. Europe Ankylosing Spondylitis Drug Revenue Market Share by Country (2017-2028)

Figure 52. Germany Ankylosing Spondylitis Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. France Ankylosing Spondylitis Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. United Kingdom Ankylosing Spondylitis Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Russia Ankylosing Spondylitis Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Italy Ankylosing Spondylitis Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Asia-Pacific Ankylosing Spondylitis Drug Sales Market Share by Type (2017-2028)

Figure 58. Asia-Pacific Ankylosing Spondylitis Drug Sales Market Share by Application (2017-2028)

Figure 59. Asia-Pacific Ankylosing Spondylitis Drug Revenue Market Share by Region (2017-2028)

Figure 60. China Ankylosing Spondylitis Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Japan Ankylosing Spondylitis Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. South Korea Ankylosing Spondylitis Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. India Ankylosing Spondylitis Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Southeast Asia Ankylosing Spondylitis Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Australia Ankylosing Spondylitis Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. South America Ankylosing Spondylitis Drug Sales Market Share by Type (2017-2028)

Figure 67. South America Ankylosing Spondylitis Drug Sales Market Share by Application (2017-2028)

Figure 68. South America Ankylosing Spondylitis Drug Revenue Market Share by Country (2017-2028)

Figure 69. Brazil Ankylosing Spondylitis Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Argentina Ankylosing Spondylitis Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Middle East and Africa Ankylosing Spondylitis Drug Sales Market Share by Type (2017-2028)

Figure 72. Middle East and Africa Ankylosing Spondylitis Drug Sales Market Share by Application (2017-2028)

Figure 73. Middle East and Africa Ankylosing Spondylitis Drug Revenue Market Share by Country (2017-2028)

Figure 74. Turkey Ankylosing Spondylitis Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Saudi Arabia Ankylosing Spondylitis Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. UAE Ankylosing Spondylitis Drug Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Methodology

Figure 78. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz